Updated 04:01 GMT, 29 Oct 2026 SPX 7,743.98 +0.28% NDX 29,813.16 +0.55% VIX 16.91 -3.48% GOLD 4,051.60 -0.56% CL 102.78 +2.88% BTC 79,693.74 -1.38%
NAS100 29,813 +0.55% S&P 7,744 +0.28% GOLD $4,052 −0.56% BTC $79,694 −1.38% VIX 16.91 −3.48% latest tape · as of 04:01 UTC
The Screen · Basic Materials · Copper

Taseko Mines Limited logoTaseko Mines Limited

TGB · NYSE American · USD · Market cap $2.9B

Taseko Mines Limited, a mining company, acquires and develops mineral properties.

PASS · Titan Ethical · score 70.0
8.08 USD

Price as of 28 Oct 2026Daily close, not a live quote

Screened 2026-10-28 · the tape above runs as of 04:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price8.08 USD at the 28 Oct 2026 close
  • Ethical screenPasses, score 70.0 out of 100
  • OptionsOpen interest leans heavily to calls (put/call 0.54)
  • Last reviewed28 Oct 2026 (1 days ago)

A summary of the dated readings below, not a live quote and not advice.

PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
8.748.7410.05

What this means: price 8.08 against the desk's fair-value range, base estimate 8.74, over the last year.

Current read
Markdown ?
Screened · screened 2026-10-28
  • Trend Markdown
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 0.54, read 2026-10-28
  • Ethical passes the values gate
Price8.08 USD
Fair value8.74
Ethical score70.0/100
Our investment reviews on this name
2026-10-18Read Markdown8.09-0.1% to today ✓Accumulation gives way to Markdown after a 10% slide in 7 days
2026-10-11Read Accumulation8.95-9.7% to today Distribution gives way to Accumulation
2026-09-14Read Distribution9.23-12.5% to today ✓Markup gives way to Distribution after an 11% rise in 4 weeks
2026-08-14Read Markup8.32-2.9% to today Distribution gives way to Markup after an 11% rise in 6 weeks

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markdown label.

Taseko Mines Limited holds its Markdown at $8.08. Elevated stress, defensive posture warranted, held for 50 days.

As held on the ledger · 2026-10-28
PhaseMarkdown · caution
Quantitative stateElevated stress, defensive posture warranted, held for 50 days
Price at the screen$8.08
Valuation398.00 trailing · 9.63 forward price to earnings
Values screenPASS · score 70.0
Beta2.09
The Workings

Five Screens, Shown in Full

Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 30.21% Below 33% Interest-bearing debt is just 30.2% of its assets, well under the one-third ceiling: it does not run on borrowed money. Pass
Interest-bearing cash 0.10% Below 33% Cash held in interest-bearing accounts and securities is 0.1% of assets, under the one-third limit. Pass
Receivables 8.12% Below 49% Money owed to the company is 8.1% of assets, under the 49% limit. Pass
Revenue purity 0.58% Below 5% Only 0.6% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Clears, in Plain English

Taseko Mines clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 30%, inside the ~33% line, and almost none of its income is interest, so it passes.

Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when TGB's ethical verdict changes

Today TGB passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

8.74Conservative8.74Base case10.05Growth case 8.08Price

Fair value range in USD, drawn from the 2026-10-28 screen. The gold marker is the market price at the same screen. A 8.2% margin of safety to the base estimate.

Reading the gap · Both our model and the analysts see meaningful upside from here.

Price History & Projections
$11.2$5.9$0.7TODAY5y agoPROJECTIONStreet avg$10.49 +64%Street high$10.49 +64%Conservative$8.74 +36%Our fair value$8.74 +36%

Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-28 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Copper miner at low multiple risks value trap

Picture a miner chasing copper prices that swing like a bar tab in a boom town. Taseko shows seventy percent revenue growth yet posts just two percent profit margins and two percent return on equity, leaving little cushion when metal prices turn. The six percent margin of safety to fair value offers scant protection in a sector where earnings peak and trough without warning.

The eight point five times forward earnings multiple looks attractive on the surface, and the single analyst note leans strongly bullish. Yet that reading ignores how cyclical miners often appear cheapest right before volumes and prices reset. Unknown competitive edge adds another layer of uncertainty around sustained returns.

Ethical checks clear without issue, yet the business still fails our opportunity test because low multiples in copper frequently signal peak earnings rather than bargains. Currency swings and project delays sit among the obvious downsides. Analysis, not advice.

The fundamentals · plain-English read
Forward P/E9.6xcheap for a company growing this fast
Trailing P/E398.0xexpensive: the price assumes strong growth ahead
EPS, trailing0.02
EPS, forward0.83
Revenue growth+184.8%growing very fast
Profit margin1.6%barely profitable
Return on equity2.2%a modest return on shareholder capital
FCF yield-3.59%
Debt to equity0.89moderate, manageable leverage
Current ratio1.24adequate liquidity, worth monitoring
Beta2.09much more volatile than the market
52-week range3.66 - 9.82
Market cap$2.9B

The risks · The things to watch: it already moves more than the market on an average day; its business and earnings are exposed to Canada and to currency swings.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

TGB trades on NYSE American (the company is based in Canada). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-10-25 Markdown $7.96 -1.6% Entry 9

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 6% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 115%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (1 analysts) rates it strong buy, with a mean price target of $8.

2026-10-18 Markdown · changed $8.09 -9.6% Entry 8

The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 9.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 25% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 115%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (1 analysts) rates it strong buy, with a mean price target of $8.

2026-10-11 Accumulation · changed $8.95 +3.2% Entry 7

The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 25% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 115%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (1 analysts) rates it strong buy, with a mean price target of $8.

2026-10-02 Distribution $8.67 -6.1% Entry 6

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 6.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 25% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 115%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (1 analysts) rates it strong buy, with a mean price target of $8.

2026-09-14 Distribution · changed $9.23 +10.9% Entry 5

The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 10.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 25% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 115%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (1 analysts) rates it strong buy, with a mean price target of $8.

2026-08-14 Markup · changed $8.32 +10.9% Entry 4

The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 10.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 25% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 115%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (1 analysts) rates it strong buy, with a mean price target of $8.

2026-07-18 Distribution $7.50 +0.0% Entry 3

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 25% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 115%. Our forward projection puts the odds of a 10% gain over the next month near 38%. The street (1 analysts) rates it strong buy, with a mean price target of $8.

2026-07-03 Distribution $7.50 +0.0% Entry 2

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.

2026-07-02 Distribution $7.50 Entry 1

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on TGB

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in TGB's Space

Screened names in the same industry · explore each on its own page.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $7.57 -15.3% · $847 -15.3%
2 months $7.29 -12.1% · $879 -12.1%
3 months $7.01 -8.6% · $914 -8.6%
6 months $5.44 +17.8% · $1,178 +17.8%
1 year $2.98 +115.1% · $2,151 +115.1%
2 years $2.45 +161.6% · $2,616 +161.6%
3 years $1.38 +364.5% · $4,645 +364.5%
5 years $2.40 +167.1% · $2,671 +167.1%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever TGB does next, these words stay.

Taseko Mines Limited · TGB · Markdown · $8.08
Recorded 2026-10-28 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.